Loading...

MedXY News - precision medicine

MedXY AI/MedXY News/Tag: precision medicine

MedXY News

EnglishTag

precision medicine

48 all articles · 20 / page

Ask MedXY AI

clinical trial type 2 diabetes heart failure immunotherapy obesity atrial fibrillation Cardiology oncology cardiovascular risk biomarkers clinical trials public health Hypertension critical care breast cancer artificial intelligence Alzheimer's disease diabetes nutrition chronic kidney disease cardiovascular disease Pediatrics

Latest news

Tag

Precision Prescribing of SGLT2 Inhibitors in People With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study

Precision Prescribing of SGLT2 Inhibitors in People With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study

The SABRE model estimates which people with type 2 diabetes may benefit most from SGLT2 inhibitors to prevent heart failure before it develops.

Section: CardiologyJun 10, 2026

Precision Prescribing of SGLT2 Inhibitors in Type 2 Diabetes for Primary Prevention of Heart Failure

Precision Prescribing of SGLT2 Inhibitors in Type 2 Diabetes for Primary Prevention of Heart Failure

A validated model, SABRE, estimates who with type 2 diabetes may gain the most heart-failure prevention benefit from SGLT2 inhibitors, enabling more precise, individualized prescribing.

Section: CardiologyJun 3, 2026

Integrating Rare and Common Variants: The Synergistic Role of rCNVs and Polygenic Scores in Psychiatric Risk Stratification

Integrating Rare and Common Variants: The Synergistic Role of rCNVs and Polygenic Scores in Psychiatric Risk Stratification

This review synthesizes evidence on how recurrent copy number variants (rCNVs) and polygenic scores (PGSs) jointly influence psychiatric risk, highlighting their complementary roles in clinical risk assessment and the emergence of precision

Section: Clinical UpdatesMay 31, 2026

Cardiovascular Benefit of CPAP May Be Greater in High-Risk Obstructive Sleep Apnoea

Cardiovascular Benefit of CPAP May Be Greater in High-Risk Obstructive Sleep Apnoea

This pooled analysis found that CPAP may lower cardiovascular event risk mainly in patients with high-risk obstructive sleep apnoea, especially those with stronger heart-rate surges or greater oxygen deprivation during sleep.

Section: CardiologyMay 15, 2026

Precision Blood-Based Diagnostics for Alzheimer’s Disease: The Synergistic Role of Plasma p-tau217 and eMTBR-tau243

Precision Blood-Based Diagnostics for Alzheimer’s Disease: The Synergistic Role of Plasma p-tau217 and eMTBR-tau243

This review synthesizes recent clinical evidence on the integration of plasma p-tau217 and eMTBR-tau243, highlighting how sequential biomarker testing improves the diagnosis of symptomatic Alzheimer’s disease and predicts longitudinal cogni

Section: Clinical UpdatesApr 10, 2026

Precision Phenotyping in Cardiometabolic Medicine: Genetic Susceptibility of Diabetes Subtypes and Coronary Artery Disease Risk

Precision Phenotyping in Cardiometabolic Medicine: Genetic Susceptibility of Diabetes Subtypes and Coronary Artery Disease Risk

This review synthesizes evidence on the genetic architecture of adult-onset diabetes subtypes, highlighting that Moderate Obesity-related Diabetes (MOD) is uniquely and causally linked to coronary artery disease risk through polygenic and M

Section: CardiologyApr 3, 2026

Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus

Beyond a Uniform Approach: Data-Driven Phenotyping Reveals High-Risk Clusters in Gestational Diabetes Mellitus

A groundbreaking machine learning study of over 37,000 patients identifies four distinct GDM phenotypic clusters. These findings demonstrate that early-diagnosed, high-comorbidity phenotypes carry a four-fold increased risk of postpartum di

Section: Diabetes & EndocrinologyMar 22, 2026

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome

Beyond the Aorta: Genetic Stratification Redefines Mitral Valve Risk in Marfan Syndrome

A breakthrough study reveals that specific FBN1 genotypes, particularly in-frame variants in the DNCD region, significantly elevate the risk of early mitral valve surgery in Marfan syndrome patients, paving the way for genotype-guided clini

Section: CardiologyMar 11, 2026

Global Diversity in Autoimmune Gastritis: Deciphering Regional Phenotypes and Neoplastic Risks

Global Diversity in Autoimmune Gastritis: Deciphering Regional Phenotypes and Neoplastic Risks

An international multicentre study of 1,240 patients reveals that autoimmune gastritis presentation varies by region, with distinct risk factors—including age, intestinal metaplasia, and extreme hypergastrinemia—driving the development of g

Section: GastroenterologyMar 10, 2026

Mapping Multimorbidity in Severe Asthma: Defining Replicable Phenotypes to Optimize Personalized Care

Mapping Multimorbidity in Severe Asthma: Defining Replicable Phenotypes to Optimize Personalized Care

This review analyzes findings from the pan-European SHARP registry study, identifying distinct multimorbidity phenotypes in severe asthma. It highlights the impact of steroid-associated and sinonasal clusters on clinical outcomes, advocatin

Section: Allergy & ImmunologyMar 4, 2026

Synergistic Benefits of Plant-Based Lifestyles and Genetic Resilience: A New Paradigm for Coronary Heart Disease Prevention

Synergistic Benefits of Plant-Based Lifestyles and Genetic Resilience: A New Paradigm for Coronary Heart Disease Prevention

This review synthesizes findings on the hPDI-Lifestyle score, demonstrating that adherence to a healthy plant-based diet combined with ideal behaviors significantly mitigates coronary heart disease risk, particularly among those with high g

Section: CardiologyMar 6, 2026

Moving Beyond Birthdays: Five-Year Absolute Risk-Based Screening Outperforms Age-Based Mammography

Moving Beyond Birthdays: Five-Year Absolute Risk-Based Screening Outperforms Age-Based Mammography

A CISNET modeling study demonstrates that mammography screening tailored to 5-year absolute invasive breast cancer risk reduces false-positive recalls by up to 23% while maintaining or improving mortality benefits compared to traditional ag

Section: newsFeb 10, 2026

Genetic Blueprints of Skin Fragility: Predicting RDEB Severity Through COL7A1 Variant Mapping

Genetic Blueprints of Skin Fragility: Predicting RDEB Severity Through COL7A1 Variant Mapping

A systematic review of 1,802 patients reveals that COL7A1 variant type and location, particularly premature termination codons and NC1 domain involvement, are definitive predictors of clinical severity and systemic complications in recessiv

Section: DermatologyFeb 5, 2026

Predicting the Clock: Machine Learning Refines Insulin Timing in Gestational Diabetes Management

Predicting the Clock: Machine Learning Refines Insulin Timing in Gestational Diabetes Management

A secondary analysis of the EMERGE trial reveals that Random Survival Forest models utilizing early glycemic data can accurately predict the time to insulin initiation in women with gestational diabetes, offering a roadmap for personalized

Section: Diabetes & EndocrinologyFeb 4, 2026

Can We Predict Who Benefits? Baseline Insulin Secretion as a Gatekeeper for Abatacept Efficacy in Stage 1 T1D

Can We Predict Who Benefits? Baseline Insulin Secretion as a Gatekeeper for Abatacept Efficacy in Stage 1 T1D

A post-hoc analysis demonstrates that baseline insulin secretion identifies responders to abatacept in Stage 1 T1D. High-secretors experienced a 15.8-month delay in disease progression and a 54% reduction in risk, providing the first eviden

Section: Diabetes & EndocrinologyFeb 4, 2026

Precision Medicine Outperforms Standard Albuminuria Thresholds for SGLT2 Inhibitor Selection in Type 2 Diabetes

Precision Medicine Outperforms Standard Albuminuria Thresholds for SGLT2 Inhibitor Selection in Type 2 Diabetes

A new precision medicine model identifies high-benefit patients for SGLT2 inhibitor treatment even when albumin levels appear normal, potentially preventing 10% more kidney failure events than current guidelines that rely solely on albuminu

Section: Diabetes & EndocrinologyFeb 3, 2026

Precision Immunotherapy in Pneumonia: Presepsin-Guided Anakinra Significantly Reduces Organ Dysfunction and Mortality

Precision Immunotherapy in Pneumonia: Presepsin-Guided Anakinra Significantly Reduces Organ Dysfunction and Mortality

The Phase IIa INSPIRE trial demonstrates that early administration of anakinra, guided by the presepsin biomarker, reduces the risk of organ dysfunction by 30% and significantly improves 90-day survival in hospitalized pneumonia patients, m

Section: Critical CareJan 30, 2026

Activating EGFR L858R Variants Linked to Syndromic Generalized Acanthosis Nigricans and Pulmonary Risk: A New Clinical Entity

Activating EGFR L858R Variants Linked to Syndromic Generalized Acanthosis Nigricans and Pulmonary Risk: A New Clinical Entity

This study identifies activating EGFR L858R variants as the genetic basis for a syndrome featuring generalized acanthosis nigricans and lung nodules, highlighting the efficacy of EGFR inhibitors in treating both cutaneous and systemic manif

Section: DermatologyJan 28, 2026

Sepsis Subtypes Are Fluid: How ‘Fuzzy’ Classification Explains Treatment Variability and Patient Trajectories

Sepsis Subtypes Are Fluid: How ‘Fuzzy’ Classification Explains Treatment Variability and Patient Trajectories

A large-scale study of 35,691 sepsis patients reveals that clinical subtypes are highly dynamic, with 82% of patients changing categories within 48 hours. This classification uncertainty significantly impacts treatment response and long-ter

Section: Critical CareJan 27, 2026

Beyond the Scalpel: How ctDNA Blood Tests are Revolutionizing Head and Neck Cancer Monitoring

Beyond the Scalpel: How ctDNA Blood Tests are Revolutionizing Head and Neck Cancer Monitoring

A new study reveals that ‘tumor-informed’ blood tests can detect recurring head and neck cancer months before traditional scans, offering a critical window for intervention in high-risk patients.

Section: newsJan 25, 2026

Prev 1 2 3 Next